Can cigarette alternativesdeliver a safer fix?

Environmental Health Perspectives

Volumn 119, Issue 7, 2011, Pages

  Washam, Cynthia ^a  

^a Oncology Times Other science and medical publications ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; NICOTINE; NITROSAMINE;

ARTICLE; CANCER CELL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; HEALTH HAZARD; HUMAN; LEUKOPLAKIA; LUNG CANCER; MOUTH CANCER; PASSIVE SMOKING; PRIORITY JOURNAL; PUBLIC HEALTH; SMOKING CESSATION; TOBACCO DEPENDENCE; CHEMISTRY; METHODOLOGY; NOTE; PSYCHOLOGICAL ASPECT; SMOKELESS TOBACCO; SMOKING; UNITED STATES;

HUMANS; SMOKING; TOBACCO USE CESSATION; TOBACCO, SMOKELESS; UNITED STATES;

EID: 79960063088     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.119-a286     Document Type: Article

References (16)

1. Phillips CV, Heavner KK. Smokeless tobacco: the epidemiology and politics of harm. Biomarkers 14 (suppl 1):79-84 (2009); PMID:19604065.
2. Gartner CE, et al. Should the health community promote smokeless tobacco (snus) as a harm reduction measure? PLoS Med 4(7):e185 (2007); doi:10.1371/journal.pmed.0040185.
3. Carpenter CM, et al. Developing smokeless tobacco products for smokers: an examination of tobacco industry documents. Tob Control 18(1):54-59 (2009); doi:10.1136/tc.2008.026583.
4. Martinet Y, et al. Would alternate tobacco products use be better than smoking? Lung Cancer 53(1):1-4 (2006); doi:10.1016/j.lungcan.2006.03.006.
5. Stanfill SB, et al. Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specific N-nitrosamines. Tob Control 20(3):e2 (2011); doi:10.1136/tc.2010.037465.
6. Hoffmann D, Hoffmann I. The changing cigarette, 1950-1995. J Toxicol Environ Health 50(4):307-364 (1997); PMID:9120872.
7. NTP. Report on Carcinogens, Twelfth Edition, 2011. Research Triangle Park, NC:National Toxicology Program, Public Health Service, U.S. Department of Health and Human Services (2011). Available: http://tinyurl.com/6446t85 [accessed 26 May 2011].
8. Kallischnigg G. Systematic review of the relation between smokeless tobacco and non-neoplastic oral diseases in Europe and the United States. BMC Oral Health 8:13 (2008); doi:10.1186/1472-6831-8-13.
9. Rainey CL, et al. Chemical characterization of dissolvable tobacco products promoted to reduce harm. J Agric Food Chem 59(6): 2745-2751 (2011); doi:10.1021/jf103295d.
10. Sottera, Inc. v. Food & Drug Administration, Civ. No. 09-cv-0771(RJL), (D.C. Cir. 2010). Available: http://tinyurl.com/3ru3pak [accessed 26 May 2011].
11. Deyton LR, Woodcock J. Regulation of E-Cigarettes and Other Products. Washington, DC:U.S. Food and Drug Administration (25 Apr 2011). http://tinyurl.com/3bwj56e [accessed 26 May 2011].
12. Family Smoking Prevention and Tobacco Control Act of 2009. Public Law No. 111-31. Available: http://tinyurl.com/d9o5mt [accessed 26 May 2011].
13. Center for Drug Analysis and Research. Evaluation of E-Cigarettes. St. Louis, MO:Center for Drug Evaluation and Research, U.S. Food and Drug Administration (4 May 2009). Available: http://tinyurl.com/3rgvknu [accessed 26 May 2011].
14. Siegel MB, et al. Electronic cigarettes as a smoking cessation tool: results from an online survey. Am J Prev Med 40(4):472-475 (2011); doi:10.1016/j.amepre.2010.12.006.
15. CDC. Youth Risk Behavior Surveillance-United States, 2009. MMWR Surveill Summ 59(SS-5) (2010); PMID:20520591.
16. Tomar SL. Is use of smokeless tobacco a risk factor for cigarette smoking? The U.S. experience. Nicotine Tob Res 5(4):561-569 (2003); doi:10.1080/1462220031000118667